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Last fall, the Editors of the journal Congestive Heart
Failure, Drs. Marc Silver and John Strobeck, asked me to
serve as Guest Editor for an issue of the journal. Accepting
this honor was linked to the requirement that I had to gener-
ate a meaningful theme. The thought of delivering another
series of articles on CHF trials and their interpretation,
bench-to-bedside (and vice-versa) topics in heart failure, and
similar efforts did little to excite me and, in fact, it threatened
to exacerbate my narcoleptic condition. Besides, we have
many colleagues more skilled at delivering this information
and they truly enjoy doing so.
We have fortunately entered the era of “evidence-based
medicine”; this theme will likely remain with us for the entire
lifetime of health care delivery. While most physicians have
now joined this movement, it is remarkable how much of the
day-to-day medical care of the patient with heart failure has
not yet been addressed by statistically powered (i.e., evidence-
based) trials. Much (probably most) of what we do to keep
patients as healthy and functional as possible is still based on
our experience as clinicians and on the information shared
by colleagues (personal contact, consultation, conferences,
written material). It is not often that data from a large treat-
ment trial assist me in determining the optimal dose of a
drug or doses of combinations in an individual patient, in
optimizing the immediate care and management of a com-
plexly ill patient, in addressing the emergency phone call at 
2 a.m., and so forth.
Until statistically powered trials can address all aspects
and details of patient care, “experience-based medicine”
must fill the knowledge void. Unfortunately, much of this in-
formation is not available in textbooks, review articles, the
Internet and other media. As the passionate fervor of evi-
dence-based medicine soars to its fever pitch, there will be
even less incentive to share in print potentially helpful infor-
mation based on clinical experience. In his submission to this
issue, Thomas D. Giles, MD, wrote, “I am fearful that valu-
able contributions to patient care will be lost and sacrificed
on the altar of 'evidenced-based' medicine (usually referring
to data from clinical trials). While I certainly believe that im-
portant concepts emanate from clinical trials, I also believe
that there are other sources of guidance for the care of pa-
tients. The Reverend Bayes reminded us that intuition and
prior experience are an integral part of the analysis of data.”
Parenthetically, most of the questions addressed by trials and
the design of trials are largely based on information gleaned
from clinical experience.
It is in this spirit that the Editors, Drs. Silver and
Strobeck, Le Jacq Communications, Inc., and I present to you
the first installment in a four-part series. The fuel for this
project has both a historical and a pragmatic thrust; “it
would be a shame” if we allowed our venerable colleagues to
advance into the autumn of their careers or even retire with-
out learning about their insights, thoughts, and passions re-
garding patient care, which grew out of decades of focused,
intense clinical experience. Instead of less, we need to hear
more from Drs. Chatterjee, Cohn, Armstrong, and colleagues.
This series is not intended to serve as a comprehensive
treatise on the management of heart failure. In fact, the
authors assume that the reader is reasonably well versed in
this area of study and practice. The content of each au-
thor’s submission was not substantially altered by the edi-
tors and staff. Any disagreements that we and fellow
coauthors may have regarding any submission were set
aside so as to allow a free and open rendering of views
and opinions. We are asking you, the reader, to judge and
decide for yourself which of the “nuggets and pearls” are
palatable and useful in your practice and in the day-to-
day care of your patients afflicted with heart failure.
To give you a better sense of the format and content of this
series, I am sharing with you the directive I sent to each
author in the letter of invitation: 
I would like you to contribute a piece on helpful tips, sug-
gestions, maneuvers, and approaches that have been help-
ful to you (and your patients) over the years in the
evaluation, management, and therapy of CHF. Every-
thing is fair game. Much of the material will not have
been previously published and is certainly not yet evidence-
based. Basically, much of what we do in our day-to-day
management of CHF patients is still related to simple clin-
ical experience, doing what works, and our own ‘tricks of
the trade.’ It is my intent to get these ideas, experiences,
and thoughts into print. The publication should serve as a
rich source of clinical insight, experience, and informa-
tion, and perhaps will serve as a springboard for further
studies and evidence-generating trials. With the 
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With the hundreds of heart failure experts located across
this country and Canada, the selection of authors was a se-
rious challenge. The selection targeted physician-scientists
with at least two decades of heart failure experience, a sig-
nificant publication record of peer-reviewed investigation
in heart failure, and known, masterful clinical expertise in
human heart failure at the bedside. Under the directive of
the Guest Editor and taking advantage of my own lack of
discretion, I added my name to the list of authors. A few of
those invited could not contribute to the manuscript, thus
accounting for the absence of certain authors. The Editors
and I deeply apologize to those who were not invited to con-
tribute because of our inadvertent oversight. If this venture
is successful and well received, you are likely to be part of
similar endeavors planned over the coming years. 
The coauthors and I dedicate this collection of insights
and views to our teachers, who have collectively consisted of
our patients, students, colleagues, and mentors. I thank
Dr. Silver and Dr. Strobeck for this honor, and I thank my
esteemed coauthors and colleagues for making this an edu-
cational and enjoyable experience for me.
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The value of a good history was mostly taught to
me by Dr. Proctor Harvey. I learned to delay the de-
sire to place my stethoscope on the patient’s chest,
and rather to spend more time listening to the pa-
tient's story. It seems that the familiar story patients
tell never gets boring or dull. The details of the story
create a clear picture of where the heart failure came
from (its etiology), where it is now (current symptoms,
functional class, major limitations), and where the
path shall lead (prognosis, goals, willingness to try
new approaches, and fears). So take the time to take a
good history. If patients are not nodding “yes” to all
your questions, consider that you’ve gone down the
wrong path. And remember their stories; often, the
only success you’ll know is remembering how awful
the story was upon your first meeting!
—Marc A. Silver
Talking to the heart failure patient is the most
important and indispensable diagnostic procedure.
In my experience, a careful history remains the sin-
gle most valuable procedure in diagnosing and as-
sessing the heart failure patient. No amount of
testing can provide the same insight into the pa-
tient’s clinical status and response to therapy. Here
are some approaches that have served me well.
1) If it’s the first time your patient has seen a
physician for a while, make sure you understand
why. It may be the key to understanding important
clinical changes in an individual who can’t or won’t
describe them.
2) In eliciting the history of the present illness, do
not simply ask when it started. Patients are often un-
aware of, or even repress, the insidious onset of an ill-
ness. They may be embarrassed at not having sought
attention earlier. Rather, it is more productive to focus
on the last time the patient felt well and define what is
meant by “well.” Determine, very specifically, what ac-
tivities the patients did when they were well, and what
activities they did not do and why. If patients are
vague, ask very specific questions. Find out what they
do at work; what their daily activities are; whether they
walk (if so, how far and, importantly, in what time; on
level ground or on a grade; one time or regularly),
climb stairs, carry groceries, etc. There is a huge differ-
ence between what patients say or think they “can do”
and what they actually do. 
3) Listen carefully to your patient, but don’t nec-
essarily accept what he or she says. Patients have a
great need to explain or understand their symp-
toms. Many attribute changes in their activity not to
intolerance, but to lack of time, stress, weight gain,
age, or specific life events.
4) Do not assume your words describe the patient’s
symptoms. Don’t simply elicit a symptom of chest pain,
but rather provide a menu of possible descriptions
(e.g., pain, discomfort, tightness, pressure, burning,
etc). Similarly, dyspnea may be described as shortness
of breath, chest tightness, coughing, etc. Fatigue needs
to be clarified as sleepiness, tiredness, exhaustion, or
muscle fatigue; precipitating factors and recovery time
need to be determined. 
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This manuscript will be presented according to the
classical clinical approach to patient care in four
parts, namely: 1. The Medical History; 2. The Physi-
cal Examination; 3. Diagnostic Studies: Laboratory
Testing; and 4. Treatment. 
Part 1–The Medical History
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5) Once the diagnosis of heart failure is made, the
most important aim of the patient interview is to quan-
tify changes in clinical status. It’s OK to ask patients
how they feel, but this should be considered a pleas-
antry rather than a symptom quantification. Many pa-
tients will state that they feel fine to please you or
because their expectations are low. Additional probing
is often required to find out how they really feel.
6) The key to assessing symptoms is to know what
activities the patient does, quantified precisely, as de-
scribed above. For each patient, you should know and
make note of the most strenuous activity performed on
a regular basis, and the activities he or she cannot do,
or that elicit symptoms. Specific questions about these
activities should be asked on each visit. Explanations of
changes attributed to such reasons as lack of time,
stress, etc. should be viewed with skepticism.
7) If you can’t tell what the patient actually can do,
go for a walk along the corridor or up a flight or two of
stairs; a 6-minute walk test can also help place a pa-
tient’s activity tolerance into perspective. Cardiopul-
monary exercise testing is certainly more quantitative,
but can’t be repeated on a regular basis and doesn’t
help in educating a patient in tracking his or her own
symptoms.
8) Most patients (especially men) tend to downplay
their symptoms. When possible, make a point of asking
a family member or friend their perception of the pa-
tient’s symptoms, again being as quantitative as possi-
ble. This should be done out of the patient’s presence,
since the third party may not want to be contradictory.
Although relatives may seem to be exaggerating symp-
toms, their descriptions are often more accurate than
that of the patient.
9) Although the goal of the patient history is to un-
derstand the patients’ clinical status, it is your best op-
portunity to help them understand their condition and
to have them participate in their own management.
Your solicitation of changes in symptoms and weight
emphasizes the importance of this information and will
provide parameters as to when they need to inform
you of these changes or self-adjust their medications.
Of course, limitations of time and reimbursement
for a careful history have made it increasingly diffi-
cult to conduct a comprehensive interview. Nonethe-
less, a careful and comprehensive initial medical
history can facilitate efficient and focused follow-up
discussions. It may seem old-fashioned to say this, but
technology cannot replace talking with the patient. 
—Barry M. Massie
There are many important, but sometimes subtle,
aspects of a patient’s history and physical examination
that give clinicians great insight into the diagnosis of
heart failure and its severity. Clinicians usually focus
on history and physical findings that detail problems
associated with a dropsical state. Symptoms and physi-
cal findings related to dyspnea, fatigue, malaise, and
edema are, naturally, our general focus. Certainly, the
more obvious components of a heart failure patient’s
history and physical examination are important, but
there are many other historical tidbits and physical
findings that can be helpful. Some of these often-ig-
nored historical points are presented in Table I. 
Of course, gathering historical information that doc-
uments and clarifies the patient’s clinical presentation is
an important task when heart failure is suspected. It
should be remembered that, though dyspnea is a hall-
mark of heart failure, it can also be due to other condi-
tions, including pulmonary disease, musculoskeletal
disease, and anemia, or simply physical deconditioning.
Non-dyspnea ancillary complaints to pursue in-
clude those rooted in gastrointestinal symptomatol-
ogy. Heart failure in its more extreme stages can
cause hepatic congestion with frank hepatopathy, as
well as more subtle mesenteric congestion. This dif-
ficulty will lead to loss of appetite, bloating, consti-
pation, nausea, and right upper quadrant fullness,
pain, or tenderness. Indeed, it is interesting to note
that younger patients with slowly progressive idio-
pathic dilated cardiomyopathy often have gastroin-
testinal difficulties as their inaugural symptoms.
Periodic respirations oftentimes reflect rather pro-
found systemic flow perturbation and low cardiac
output. Sleep apnea can cause substantive pul-
monary hypertension and be associated with signifi-
cant right heart failure and deterioration. A history
of snoring and sleep apnea must generally be elicited
from the patient’s partner or other observer, for ob-
vious reasons. Particularly in the obese patient (and
even more so in profound centripetal obesity), the
presence of early morning headache, sudden sleep
drop-off, and loud snoring should point toward peri-
Table I. Additional “Nuggets” to Remember in the 
Heart Failure History
• Gastrointestinal symptoms (loss of appetite; bloating;
constipation; right upper quadrant pain, tenderness, 
or fullness; nausea)
• Periodic respirations (snoring, sleep apnea)
• Presence of concomitant infections (upper respiratory
infection; bronchitis; cellulitis; tinea pedis/cruris)
• Neurologic and psychiatric complaints (depression;
anxiety or panic attacks; confusion; decreased mental
acuity)
• Dietary issues (salt or water craving)
• Nocturia
• Syncope, near-syncope
odic respirations being problematic, necessitating
sleep study evaluation and therapy.
Systemic infections are associated with cytokine re-
lease (sometimes cytokine storm), and we now know
that these evil humors can precipitate substantial ven-
tricular dysfunction and worsening heart failure. It is
important to pursue a history that may shed light on
upper respiratory tract infections, chronic bronchitis, or
early symptoms of pneumonia. Sometimes seemingly
minor difficulties are the nidus or problem. Tinea pedis
with ensuing foot and lower leg cellulitis is frequently
overlooked in the patient with marked peripheral
edema. This is particularly important in the patient who
has had local venectomy for bypass grafting surgery.
Tinea cruris, especially with secondary local bacterial
infection, can worsen the heart failure syndrome. 
Several neurologic and psychiatric complaints are
also important to pursue. Depression, anxiety or panic
attacks, confusion, and decreased mental acuity can be
related to heart failure and its severity. It is not unusual
to see a patient whose diagnosis of congestive heart
failure was made only after the individual was admitted
to a psychiatric unit for evaluation of “panic attacks”;
the panic attacks in these patients often turn out to be
hyperventilation symptoms due to orthopnea, paroxys-
mal nocturnal dyspnea, periodic breathing disorders,
or dyspnea on exertion caused by the cardiac failure.
Other helpful historical nuggets include presence of
nocturia and salt or water craving. Of course, syncope
in a patient with ventricular dysfunction may be omi-
nous and extremely important. Syncope can be the
hallmark of malignant ventricular arrhythmias or heart
block that requires pacing, antiarrhythmic drug thera-
py, or a defibrillating device. 
—James B. Young
An atypical history at presentation can often lead to
misdiagnosis (Table II). It is not uncommon for pa-
tients with heart failure to present with a “flu-like ill-
ness that I could not shake off”; “asthma” diagnosed
for the first time in adult life; bloating, abdominal dis-
comfort, and weight gain; ankle edema, often absent in
younger patients; and shortness of breath, which may 
not be volunteered as a symptom, although exercise in-
tolerance is often mentioned to the physician.
—Michael B. Fowler
Although fatigue and dyspnea on exertion are
the most common symptoms in patients with
heart failure, a number of patients present with
gastrointestinal symptoms, such as pain in the
right hypochondrium, nausea, and vomiting.
These patients will usually have an enlarged liver
and clinically, they improve after diuresis and
other congestive heart failure therapy.
—Hector O. Ventura
The family history in patients with idiopathic dilat-
ed cardiomyopathy (IDC) is more important than
ever; familial dilated cardiomyopathy (FDC) is much
more common than any of us has appreciated, and a
carefully taken family history can be very revealing.
As a heart failure/transplant fellow at the Universi-
ty of Utah, I recall IDC patients commonly asking
whether it “ran in the family.” The answer then was
“very infrequently,” which was based largely on case
reports and small series of patients. My questioning
of family history during a patient interview was cur-
sory. In 1992, I read a report of a well designed,
prospective echocardiographic study of first-degree
relatives of subjects with IDC; one in five relatives
was also found to have FDC (N Engl J Med. 1992;
326:77). I then realized I had been missing FDC for
years! Additional studies have confirmed that from
one quarter to one half of patients with IDC will have
family members similarly affected (FDC). Even
though taking a family history for FDC is less sensi-
tive than echocardiographic screening, I have repeat-
edly learned in my clinical practice and from
experience gained from my FDC research program
(established 1993) that a carefully taken family histo-
ry, with a search for a history of heart failure or un-
explained sudden cardiac death in an extended
kindred, can be very informative. It is inexpensive
and can be accomplished during the first interview in
a matter of minutes. A report of this recommenda-
tion combined with echo screening of first-degree
relatives of patients with newly diagnosed IDC has
been published (J Am Coll Cardiol. 1999;34:837). 
The genetic basis for FDC is rapidly evolving,
and a great deal of work remains. Our FDC re-
search group accepts referrals of FDC families and
patients (telephone 503-494-3203; email hersh-
ber@ohsu.edu; or Web site at http://www.fdc.to).
The Web site also provides a comprehensive review
of FDC for clinicians, information for patients and
families, and direct email access. 
—Raymond E. Hershberger
NEXT ISSUE: Part 2—The Physical Examination
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Table II. Common Misdiagnoses at Heart Failure 
Presentation
• Upper respiratory infection, bronchitis, pneumonia
• Asthma
• Liver disease, cirrhosis
• Chronic fatigue syndrome
• “Old age”
